The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Open accessAbstract
Background: Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have been of immense value to researchers who conduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies. However, their utility has not extended beyond patients with cancer or recipients of stem cell or solid organ transplants. With newer diagnostic techniques available, it was clear that an update of these definitions was essential. Methods: To achieve this, 10 working groups looked closely at imaging, laboratory diagnosis, and special populations at risk of IFD. A final version of the manuscript was agreed upon after the groups’ findings were presented at a scientific symposium and after a 3-month period for public comment. There were several rounds of discussion before a final version of the manuscript was approved. Results: There is no change in the classifications of “proven,” “probable,” and “possible” IFD, although the definition of “probable” has been expanded and the scope of the category “possible” has been diminished. The category of proven IFD can apply to any patient, regardless of whether the patient is immunocompromised. The probable and possible categories are proposed for immunocompromised patients only, except for endemic mycoses. Conclusions: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Self-citationPappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651262 · Cited by 1,570
Self-citationKontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
Self-citationMaertens, J. A., Raad, I. I., Marr, K. A., Patterson, T. F., Kontoyiannis, D. P., Cornely, O. A., Bow, E. J., Rahav, G., Neofytos, D., Aoun, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01159-9 · Cited by 1,001
Self-citationDetection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
Mennink-Kersten, M. A., Donnelly, J. P., & Verweij, P. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01045-x · Cited by 482
Self-citationClinical and Host Differences Between Infections with the Two Varieties of Cryptococcus neoformans
Speed, B., & Dunt, D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.28 · Cited by 478
Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay
Marr, K. A., Laverdiere, M., Gugel, A., & Leisenring, W. (2005) · Clinical Infectious Diseases · doi:10.1086/429921 · Cited by 471
Self-citationChen, S., Sorrell, T., Nimmo, G., Speed, B., Currie, B., Ellis, D., Marriott, D., Pfeiffer, T., Parr, D., & Byth, K. (2000) · Clinical Infectious Diseases · doi:10.1086/313992 · Cited by 467
Self-citationT2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443
Self-citationGalactomannan detection for invasive aspergillosis in immunocompromized patients
Leeflang, M. M., Debets-Ossenkopp, Y. J., Visser, C. E., Scholten, R. J., Hooft, L., Bijlmer, H. A., Reitsma, J. B., Bossuyt, P. M., & Vandenbroucke-Grauls, C. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007394 · Cited by 362
Cited by
Koehler, P., Bassetti, M., Chakrabarti, A., Chen, S. C. A., Colombo, A. L., Hoenigl, M., Klimko, N., Lass-Flörl, C., Oladele, R. O., Vinh, D. C., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30847-1 · Cited by 951
Self-citationCOVID-19 Associated Pulmonary Aspergillosis
Koehler, P., Cornely, O. A., Böttiger, B. W., Dusse, F., Eichenauer, D. A., Fuchs, F., Hallek, M., Jung, N., Klein, F., Persigehl, T., et al. (2020) · Mycoses · doi:10.1111/myc.13096 · Cited by 547
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
John, T. M., Jacob, C. N., & Kontoyiannis, D. P. (2021) · Journal of Fungi · doi:10.3390/jof7040298 · Cited by 524
Self-citationBartoletti, M., Pascale, R., Cricca, M., Rinaldi, M., Maccaro, A., Bussini, L., Fornaro, G., Tonetti, T., Pizzilli, G., Francalanci, E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1065 · Cited by 473
Verweij, P. E., Rijnders, B. J. A., Brüggemann, R. J. M., Azoulay, E., Bassetti, M., Blot, S., Calandra, T., Clancy, C. J., Cornely, O. A., Chiller, T., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06091-6 · Cited by 459
Self-citationPrevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
Alanio, A., Dellière, S., Fodil, S., Bretagne, S., & Mégarbane, B. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30237-x · Cited by 457
Self-citationWhite, P. L., Dhillon, R., Cordey, A., Hughes, H., Faggian, F., Soni, S., Pandey, M., Whitaker, H., May, A., Morgan, M., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1298 · Cited by 445
Self-citationThe emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Hoenigl, M., Seidel, D., Carvalho, A., Rudramurthy, S. M., Arastehfar, A., Gangneux, J.-P., Nasir, N., Bonifaz, A., Araiza, J., Klimko, N., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00237-8 · Cited by 443
Self-citationCOVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Arastehfar, A., Carvalho, A., van de Veerdonk, F. L., Jenks, J. D., Koehler, P., Krause, R., Cornely, O. A., S. Perlin, D., Lass-Flörl, C., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6020091 · Cited by 421
COVID-19–associated Pulmonary Aspergillosis
van Arkel, A. L. E., Rijpstra, T. A., Belderbos, H. N. A., van Wijngaarden, P., Verweij, P. E., & Bentvelsen, R. G. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1038le · Cited by 370
Self-citation2019 novel coronavirus (2019-nCoV) outbreak: A new challenge
Lupia, T., Scabini, S., Mornese Pinna, S., Di Perri, G., De Rosa, F. G., & Corcione, S. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.02.021 · Cited by 364
Diagnosis of invasive fungal infections: challenges and recent developments
Fang, W., Wu, J., Cheng, M., Zhu, X., Du, M., Chen, C., Liao, W., Zhi, K., & Pan, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00926-2 · Cited by 356
Bassetti, M., Azoulay, E., Kullberg, B.-J., Ruhnke, M., Shoham, S., Vazquez, J., Giacobbe, D. R., & Calandra, T. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1751 · Cited by 327
Self-citationGangneux, J.-P., Dannaoui, E., Fekkar, A., Luyt, C.-E., Botterel, F., De Prost, N., Tadié, J.-M., Reizine, F., Houzé, S., Timsit, J.-F., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00442-2 · Cited by 284
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020
Salmanton-García, J., Sprute, R., Stemler, J., Bartoletti, M., Dupont, D., Valerio, M., Garcia-Vidal, C., Falces-Romero, I., Machado, M., de la Villa, S., et al. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2704.204895 · Cited by 269
Self-citationEpidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Self-citationSpecificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
Finkelman, M. A. (2020) · Journal of Fungi · doi:10.3390/jof7010014 · Cited by 76
An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections
Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2267977 · Cited by 61
Self-citationCOVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series
Meijer, E. F. J., Dofferhoff, A. S. M., Hoiting, O., & Meis, J. F. (2021) · Mycoses · doi:10.1111/myc.13254 · Cited by 56
Self-citationSpallone, A., & Schwartz, I. S. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.014 · Cited by 48
Jenks, J. D., Gangneux, J.-P., Schwartz, I. S., Alastruey-Izquierdo, A., Lagrou, K., Thompson III, G. R., Lass-Flörl, C., Hoenigl, M., & Investigators, E. C. O. M. M. (. C. (2020) · Journal of Fungi · doi:10.3390/jof6040216 · Cited by 44
Self-citationWang, Y., Yang, M., Xia, Y., Yan, J., Zou, J., & Zhang, D. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06678-4 · Cited by 16
How do I manage refractory invasive pulmonary aspergillosis
Vergidis, P., Sendi, P., Alkhateeb, H. B., & Nguyen, M. H. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.01.015 · Cited by 12
Antifungal persistence: Clinical relevance and mechanisms
Wang, R., Lv, J., Chen, L., Zhao, Y., & Du, H. (2025) · PLoS pathogens · doi:10.1371/journal.ppat.1013456 · Cited by 12
Metadata
- Authors
- Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., Sorrell, T. C., Bassetti, M., Akan, H., Alexander, B. D., Andes, D., Azoulay, E., Bialek, R., Bradsher, R. W., Bretagne, S., Calandra, T., Caliendo, A. M., Castagnola, E., Cruciani, M., Cuenca-Estrella, M., Decker, C. F., Desai, S. R., Fisher, B., Harrison, T., Heussel, C. P., Jensen, H. E., Kibbler, C. C., Kontoyiannis, D. P., Kullberg, B.-J., Lagrou, K., Lamoth, F., Lehrnbecher, T., Loeffler, J., Lortholary, O., Maertens, J., Marchetti, O., Marr, K. A., Masur, H., Meis, J. F., Morrisey, C. O., Nucci, M., Ostrosky-Zeichner, L., Pagano, L., Patterson, T. F., Perfect, J. R., Racil, Z., Roilides, E., Ruhnke, M., Prokop, C. S., Shoham, S., Slavin, M. A., Stevens, D. A., Thompson, G. R., Vazquez, J. A., Viscoli, C., Walsh, T. J., Warris, A., Wheat, L. J., White, P. L., Zaoutis, T. E., & Pappas, P. G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-12-05
- Volume
- 71
- Issue
- 6
- Pages
- 1367-1376
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2992250822
- Cited by
- 2,917
- References
- 79
- FWCI
- 173.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.